Viewing Study NCT00566267


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-05 @ 12:49 AM
Study NCT ID: NCT00566267
Status: COMPLETED
Last Update Posted: 2007-12-03
First Post: 2007-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module